Generation Bio Co (GBIO) is gearing up for another turning point as it hit the volume of 0.51 million

A new trading day began on Monday, with Generation Bio Co (NASDAQ: GBIO) stock price down -3.79% from the previous day of trading, before settling in for the closing price of $0.34. GBIO’s price has ranged from $0.30 to $3.65 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales slid by -8.30% over the last five years. Meanwhile, its annual earnings per share averaged 45.62%. With a float of $45.82 million, this company’s outstanding shares have now reached $67.01 million.

The firm has a total of 115 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -331.33%, and the pretax margin is -292.92%.

Generation Bio Co (GBIO) Insider Activity

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Generation Bio Co is 31.65%, while institutional ownership is 54.39%. The most recent insider transaction that took place on Jan 10 ’25, was worth 120,759. In this transaction Director of this company bought 125,791 shares at a rate of $0.96, taking the stock ownership to the 214,286 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director bought 85,000 for $0.97, making the entire transaction worth $82,450. This insider now owns 299,286 shares in total.

Generation Bio Co (GBIO) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 45.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.37% during the next five years compared to -8.30% drop over the previous five years of trading.

Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators

Here are Generation Bio Co’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.90.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.07 in one year’s time.

Technical Analysis of Generation Bio Co (GBIO)

Analysing the last 5-days average volume posted by the [Generation Bio Co, GBIO], we can find that recorded value of 1.37 million was better than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 46.18%.

During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 6.56%, which indicates a significant decrease from 27.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.75% in the past 14 days, which was higher than the 94.25% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.3828, while its 200-day Moving Average is $1.0378. Now, the first resistance to watch is $0.3410. This is followed by the second major resistance level at $0.3519. The third major resistance level sits at $0.3613. If the price goes on to break the first support level at $0.3207, it is likely to go to the next support level at $0.3113. Should the price break the second support level, the third support level stands at $0.3004.

Generation Bio Co (NASDAQ: GBIO) Key Stats

With a market capitalization of 22.12 million, the company has a total of 67,035K Shares Outstanding. Currently, annual sales are 19,890 K while annual income is -131,670 K. The company’s previous quarter sales were 8,720 K while its latest quarter income was -14,800 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.